Combining biomarkers for prognostic modelling of Parkinson’s disease

BACKGROUND: Patients with Parkinson’s disease (PD) have variable rates of progression. More accurate prediction of progression could improve selection for clinical trials. Although some variance in clinical progression can be predicted by age at onset and phenotype, we hypothesise that this can be f...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijiaratnam, Nirosen, Lawton, Michael, Heslegrave, Amanda J, Guo, Tong, Tan, Manuela, Jabbari, Edwin, Real, Raquel, Woodside, John, Grosset, Katherine, Chelban, Viorica, Athauda, Dilan, Girges, Christine, Barker, Roger A, Hardy, John, Wood, Nicholas, Houlden, Henry, Williams, Nigel, Ben-Shlomo, Yoav, Zetterberg, Henrik, Grosset, Donald G, Foltynie, Thomas, Morris, Huw R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Movement Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279845/
https://www.ncbi.nlm.nih.gov/pubmed/35577512
http://dx.doi.org/10.1136/jnnp-2021-328365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279845/
https://www.ncbi.nlm.nih.gov/pubmed/35577512
http://dx.doi.org/10.1136/jnnp-2021-328365

Ejemplares similares